Patent · US Active

PTH compounds with low peak-to-trough ratios

US11857603B2 · kind B2 · utility

3Cited by

12References

12Claims

0Family size

Assignee

ASCENDIS PHARMA BONE DISEASES A/S · DK

Inventors

Kennett Sprogøe · Rudegård, DK
Lars Holten-Andersen · Vanløse, DK
David Karpf · Mountain View, US
Felix Cleemann · Mainz, DE
Guillaume Maitro · Mannheim, DE
Mathias Krusch · Hirschhorn, DE
Thomas Wegge · Heidelberg, DE
Joachim Zettler · Heidelberg, DE

Key dates

Filing date	Nov 8, 2022
Grant date	Jan 2, 2024
Priority date	—
Expiry date	Nov 8, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P5/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical composition comprising a PTH compound, wherein after subcutaneous administration the pharmacokinetic profile of the PTH compound exhibits a peak to trough ratio of less than 4 within one injection interval.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.